Flora Ventures

Flora Ventures

Founded by Gil Horsky, Flora Ventures operates from Tel Aviv with an investment lens shaped by Horsky's two decades inside the global food system. Before launching the firm, Horsky co-founded Mondelēz International's corporate venture arm, SnackFutures, and held commercial leadership roles at Kraft Foods, PepsiCo, and Nestlé. His operating experience spans iconic brands — Milka, Oreo, Gatorade, Cadbury — and more than $800 million in launched innovation revenue. The firm targets early-stage and seed-stage companies applying technology to the agrifood supply chain, novel ingredients, and health-focused food platforms. Flora Ventures evaluates opportunities through what it calls the "3 P's" criteria, emphasizing purpose alongside performance, though the fund's portfolio reveals a pragmatic concentration on scalable science and manufacturing innovation. Confirmed portfolio positions include Incredo, a sugar-reduction platform; Celleste Bio, which engineers cell-cultured cocoa; Bluewhite, an autonomous-tractor robotics company; and Israeli plant-based meat producer Chunk Foods. The portfolio reaches across Israel, the United States, and European agritech markets. The firm's architecture is that of a classic emerging venture manager — sole named partner, concentrated early-stage bets, and reliance on an expert network rather than a large internal team. Horsky leverages his membership in World.Minds and Toniic, global communities of investors and thought leaders, as part of the firm's value-add model: connecting portfolio companies to multinational commercial partners and follow-on capital. No additional offices outside Tel Aviv are disclosed, reflecting a lean, Israel-centric operational footprint. Its structural differentiator is a genuine operator-first, single-partner focus on the narrowest band of food system venture. While corporate venture capital funds routinely dabble in agritech, a standalone vehicle run by a former global innovation executive for the world's largest snacking company creates unusual alignment: portfolio companies get a direct line to the commercial realities of scaling inside a multinational supply chain, without the fund itself being beholden to a corporate parent's quarterly calendar.